Let's talk about the elephant in the room — or more accurately, the injection pen in the mini-fridge. GLP-1 agonists (Wegovy, Ozempic, Mounjaro, Zepbound) are everywhere in Austin. I see the pens in people's fridges at parties (yes, I look in fridges — habit from my data-collection days). At Life Time on South Lamar, half the personal trainers have a "weight loss medication management" add-on to their services. On the SXSW 2026 Health Track floor, every other booth had a GLP-1 referral service. The evidence is undeniable: these drugs produce 10-15% body weight loss on average across clinical trials. The STEP trials for Wegovy showed 14.9% at 68 weeks. The SURMOUNT trials for Mounjaro showed 20.9% at 72 weeks. Those are real numbers from real studies.
But the out-of-pocket cost is $900-$1,400 per month without insurance. Many insurance plans don't cover GLP-1s for BMI under 35 without comorbidities like diabetes, hypertension, or sleep apnea. Even with insurance, copays can be $200-400 per month, plus prior authorization hassles, plus supply shortages. The FDA listed semaglutide on the shortage list for most of 2024 and 2025. I know people who drove to three pharmacies in one day trying to fill a prescription. So what do you do if your BMI is 30-34, you're prediabetic or have high blood pressure, but you can't afford the real thing or your insurance denied coverage?
I spent two months digging through the literature on "GLP-1 alternatives" — repurposed generic drugs, over-the-counter supplements, and intensive lifestyle interventions — to see what actually moves the needle. I limited my search to interventions with at least one randomized controlled trial in adults with BMI over 30, published in a peer-reviewed journal since 2020. No anecdotes, no case studies, no "I took this and lost 30 pounds" influencer posts. Just data.
Disclaimer: I am not a doctor. This is not medical advice. I am a data analyst who read papers. Talk to your physician before starting any medication or supplement, especially if you have diabetes or are on other medications.
Option 1: Metformin. Old drug, FDA approved 1995 for type 2 diabetes, cheap ($15-30 per month without insurance, often $5 with insurance or $0 at H-E-B pharmacy for the generic), widely available. A 2024 systematic review in Diabetes Care pooled 22 randomized trials with 5,600 adults with BMI over 30, most with prediabetes or PCOS. The intervention was metformin (1,500-2,000 mg per day) plus lifestyle counseling. At 6 months, metformin plus lifestyle produced 4.2% weight loss. Placebo plus lifestyle produced 1.8%. The net effect from metformin was 2.4%. For reference, Wegovy plus lifestyle from the STEP-1 trial produced 11.2% weight loss.
So metformin produces about 20-25% of the weight loss effect of Wegovy. That is not nothing — 4% of 250 pounds is 10 pounds. Clinically meaningful. Metformin also improves insulin sensitivity, reduces progression from prediabetes to diabetes by 31% in the DPP trial, lowers fasting glucose, and has a 30-year safety record. Downside: GI side effects in 20-30% of people — diarrhea, nausea, bloating — though these often resolve after 2-4 weeks or with extended-release formulation. I tried it myself for three months. The first week was rough. After that, my body adapted. I lost 6 pounds and my fasting glucose dropped from 102 to 91.
Option 2: Berberine. This is the "nature's Ozempic" supplement you see on TikTok. Berberine is a plant alkaloid found in goldenseal, barberry, and other herbs. It activates AMPK, the same metabolic pathway as metformin, and has shown glucose-lowering effects. A 2023 meta-analysis in Frontiers in Pharmacology reviewed 14 RCTs with 1,100 adults with BMI over 27 and metabolic syndrome. Berberine at 500 mg three times daily plus lifestyle produced 3.8% weight loss at 3 months. Placebo plus lifestyle produced 1.2%. The net effect from berberine was 2.6%.
No head-to-head versus metformin in that meta-analysis, but a 2022 trial with 100 participants found no significant difference between berberine (500mg three times daily) and metformin (500mg three times daily) for weight loss at 6 months: 3.9% versus 4.1%, statistically indistinguishable. Cost is $20-30 per month for quality-controlled brands. I use the one sold at H-E-B pharmacy, Nature's Bounty, USP-verified, about $22 for a 60-capsule bottle. Quality control matters: a 2023 JAMA research letter tested 12 berberine supplements sold online; 5 had less than 80% of labeled dose, 2 had detectable heavy metals. Stick with USP-verified or a brand your pharmacist trusts. GI side effects are similar to metformin — diarrhea in about 15% of users in trials.
Option 3: High-protein, high-fiber dietary intervention. Not sexy, but the data is solid. A 2025 New England Journal of Medicine trial with 300 participants, BMI 30-35, mean age 48, 65% female, randomized participants to three arms for 6 months. Group 1 got standard dietary advice — generic "eat less, move more" handout. Result: minus 2.1% body weight. Group 2 got semaglutide 2.4mg per week plus standard advice. Result: minus 11.4%, consistent with STEP trials. Group 3 got high-intensity lifestyle: 35% of calories from protein, 30g fiber per day, 3 times per week strength training, weekly coaching calls. Result: minus 6.8% body weight.
Six point eight percent is not 11.4%. But it is also not nothing — 7% of 250 pounds is 17.5 pounds. And it costs $0, plus food, which you are buying anyway. The catch: adherence in Group 3 was only 54% at 6 months, defined as meeting at least 2 of 3 targets on 5 of 7 days per week. In Group 2, medication adherence was 89%. The lifestyle intervention works if you stick to it. Most people don't. The GLP-1 makes adherence easier because it reduces hunger and food noise. That is the real advantage of the drug — not just the chemical effect, but the behavioral effect of not being hungry all the time.
Option 4: Intermittent fasting (16:8). A 2024 JAMA Network Open trial with 300 participants, BMI 30-45, mean age 46, compared 16:8 intermittent fasting (eating only between 12 PM and 8 PM) to daily calorie restriction (1,500 calories per day for women, 1,800 for men) for 6 months. At 6 months, the 16:8 group lost 4.6% body weight. The calorie restriction group lost 4.8%. Not statistically different. But adherence was 72% in 16:8 versus 58% in calorie restriction. Some people find it easier to follow one rule — no eating before noon — than to count calories all day.
I tried 16:8 for two months. I lost about 5 pounds. But I was hungry in the mornings and my gym performance suffered. Lifting fasted is hard. Your mileage may vary. The research says it works about as well as calorie restriction, but some people find it easier to stick with. That is the real variable — not the method, but the adherence.
What the data does not support: OTC "GLP-1 booster" supplements — berberine is the only one with decent evidence. Others like chromium, cinnamon, and bitter melon have weak or null results. Very-low-calorie diets under 800 calories per day produce rapid weight loss (10-15% at 3 months) but 80% regain at 12 months, plus muscle loss, gallstones, and electrolyte disturbances. "Metabolic confusion" or carb cycling have no RCTs showing superiority to standard calorie restriction. Herbal teas, detoxes, and cleanses have zero evidence for sustained weight loss. I have tried none of these because the data says they don't work, and I have a limited tolerance for wasting money.
My practical takeaway: If you can't afford Wegovy, don't despair. You can get 40-60% of the weight loss effect for 1-2% of the cost using metformin (prescription needed, but any primary care doctor can prescribe it for prediabetes or PCOS) or berberine (over-the-counter, but talk to your doctor first). The lifestyle part — high protein (30-35% of calories), high fiber (30g per day), strength training — does about half the work (6-7% loss in the NEJM trial). The drugs add another 2-4% on top. The GLP-1s add even more (another 5-8% beyond lifestyle) but at 50-100 times the cost.
If you are in Austin and your BMI is over 30 with a comorbidity, check if you qualify for ACA subsidies through Healthcare.gov. Some 2026 plans cover GLP-1s with a $0-50 copay if you meet criteria. The Austin Regional Clinic on South Lamar has a weight management program that includes GLP-1 counseling for patients with insurance. Gevity has a directory of metabolic health clinics in Austin that can help with prior authorizations. There are options. They just require more work than filling a prescription.
This is a tools-not-answers situation. The tool that works for you depends on your budget, your biology, your insurance, your tolerance for GI distress, and your ability to adhere to lifestyle changes. I can't tell you which one to pick. I can only show you the data. The data says: lifestyle alone works if you can stick to it. Lifestyle plus metformin or berberine works better. GLP-1s work best. But the cost gradient is steep. Choose the tool that fits your life, your wallet, and your stomach. And talk to a doctor before you start anything. Please.
What would you try first if your insurance said no?
A 2022 head-to-head trial found no significant difference: berberine produced 3.9% weight loss versus metformin's 4.1% at 6 months. Both activate AMPK. Berberine is over-the-counter but quality varies widely — stick to USP-verified brands.
High-intensity lifestyle interventions produce about 60% of the weight loss effect of GLP-1s (6-7% versus 11-15%). The catch is adherence: only 54% of people stick to intensive lifestyle programs at 6 months, versus 89% for medication.
GI upset (diarrhea, nausea) affects 20-30% of users, usually resolving in 2-4 weeks. Extended-release formulations reduce this. Metformin has a 30-year safety record and is generally well-tolerated long-term.
